Ligand profile
ZINC263615759
Virtual-screening candidate from ZINC.
Bound to: VK055_4546 — 2OG-Fe(II) oxygenase superfamily protein
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC263615759- UniProt (similar protein)
Q6EZB3- Tanimoto
- 0.810
- Target protein
- VK055_4546
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 29.5
- −1 ≤ LogP ≤ 5 3.35
- MW ≤ 500 Da 287.4
- LogP ≤ 5 3.35
- H-bond donors ≤ 5 0
- H-bond acceptors ≤ 10 3
- Rotatable bonds ≤ 10 4
- TPSA ≤ 140 Ų 29.5
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CC[C@H](C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)N2C)c1ccccc1CC[C@H](C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)N2C)c1ccccc1
InChI=1S/C18H25NO2/c1-3-17(13-7-5-4-6-8-13)18(20)21-16-11-14-9-10-15(12-16)19(14)2/h4-8,14-17H,3,9-12H2,1-2H3/t14-,15+,16+,17-/m0/s1InChI=1S/C18H25NO2/c1-3-17(13-7-5-4-6-8-13)18(20)21-16-11-14-9-10-15(12-16)19(14)2/h4-8,14-17H,3,9-12H2,1-2H3/t14-,15+,16+,17-/m0/s1
FCLAAKQIHWIKQY-HZMVEIRTSA-NFCLAAKQIHWIKQY-HZMVEIRTSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- HYO
- Homolog
- Q6EZB3
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC263615759 →
- ZINC ZINC20 ZINC263615759 →
- UniProt UniProt Q6EZB3 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC263615759”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_4546.
PDB 32
Ligands co-crystallized with this protein (structural evidence).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).